跳至主要内容
临床试验/CTRI/2023/07/055519
CTRI/2023/07/055519尚未招募不适用

Evaluation of clinical and radiographic outcome of premixed injectable MTA and conventional MTA as pulpotomy medicament in primary teeth : A split mouth randomised control trial

AISWARYA U S1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2023年7月22日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
15
试验地点
1
主要终点
Injecatble form of MTA can be used as a Pulpotomy Medicament in Primary teeth. Clinical and radiographic assessment will be done.

研究概览

简要总结

Pulpotomy is vital endodontic procedure done to maintain the integrity of the radicular pulp. This study will be done to evaluate the clinical and radiographic outcome of Premixed Injectable MTA and Conventional MTA as pulpotomy medicament in primary teeth.

研究设计

研究类型
Interventional
分配方式
Other
盲法
Participant and Outcome Assessor Blinded

入排标准

年龄范围
5.00 Month(s) 至 9.00 Year(s)(—)
性别
All

入选标准

  • Children with bilateral indication for pulpotomy without signs and symptoms of irreversible pulpal damage.

排除标准

  • Children with irreversible pulpal damage, sinus or fistula and children with systemic diseases.

结局指标

主要结局

Injecatble form of MTA can be used as a Pulpotomy Medicament in Primary teeth. Clinical and radiographic assessment will be done.

时间窗: Over a period of 6 months and one year

次要结局

  • Clinical & radiographic outcome of the pulpotomy with premixed injectable MTA will be assessed over a follow up period(12 months)

研究者

发起方
AISWARYA U S
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验

Premixed Injectable MTA for Pulpotomy of Primary... | 临床试验